Patent · US Active

Immunogenic composition

US8703148B2 · kind B2 · utility

25Cited by

0References

10Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Ralph Leon Biemans · Rixensart, BE
Philippe Denoel · Rixensart, BE
Pierre Duvivier · Rixensart, BE
Tomas Maira-Litran · Boston, US
Jan Poolman · Broek in Waterland, NL

Key dates

Filing date	Mar 29, 2007
Grant date	Apr 22, 2014
Priority date	—
Expiry date	May 30, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S424/831
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to immunogenic compositions comprising staphylococcal PNAG which is less than 40% N-acetylated and is conjugated to a carrier protein by a linker bonded to an amine group on PNAG to form a PNAG conjugate. Vaccines, methods of treatment using and processes to make an immunogenic composition comprising PNAG and Type 5 and/or 8 capsular polysaccharides are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.